Skip to content

No Time to Lose: G20 Leaders Must Fund R&D to End TB

In advance of World TB Day, Treatment Action Group (TAG), Health GAP, AIDS-Free World and Treatment Action Campaign (TAC) urge G20 member states to commit by the July 7, 2017 G20 summit to increase annual funding contributions to USD $1.17 billion for research and development (R&D) to set us on the path to end tuberculosis (TB).
Read more

Pre-CROI Community HIV Cure Research Workshop 2017

On Sunday February 12, 2017 in Seattle, the AIDS Treatment Activists Coalition, AVAC, the DARE Community Advisory Board, the defeatHIV Community Advisory Board, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research.
Read more

HCV Genotypes

February 2017 What are genotypes? A genotype is a way to put the hepatitis C virus (HCV) into categories based on similar genes. It’s important to know and understand HCV genotypes because different genotypes respond differently to medicines that treat…

Read more

The Pharma Shell Game

The global system for funding drug development socializes the costs and privatizes the pro ts though a system of taxpayer-funded research, legal corporate tax havens, and intellectual property registrations to guarantee exclusive access to markets and to reduce corporate taxes, while selling identical formulations at wildly different prices.
Read more

Story: British Scientists on Brink of HIV Cure

October 2016 Examples of media coverage:  British scientists on brink of HIV cure (headline now corrected to “British scientists hopeful for HIV cure”) – The Sunday Times, October 2, 2016 (registration required) HIV cure close after disease ‘vanishes’ from blood of British man (now…

Read more
Back To Top